A NEW HOPE FOR WEIGHT MANAGEMENT ?

Experts are rapidly examining retatrutide, a promising drug created by Eli Lilly, as a potential advance in physique loss . Distinct from many previous approaches, retatrutide is a twin-action receptor targeting both GLP-1 and GIP, hormones that influence appetite and blood glucose regulation .